Elanco Beats Investor Suit Over Dog Drug's Reg Challenges

By Katryna Perera · March 26, 2026, 8:58 PM EDT

A Maryland federal judge Thursday dismissed a proposed securities class action against Elanco Animal Health Inc. that claimed the animal pharmaceuticals company misled investors about the safety of a canine dermatitis...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Barpar et al v. Elanco Animal Health Incorporated Securities

Case Number

1:24-cv-02912

Court

Maryland

Nature of Suit

Securities/Commodities

Date Filed

October 07, 2024